Sleep Aids Market 2016: Insomnia, Sleep Apnea, Narcolepsy

Sleeps aids are drugs and medical devices that treats sleep disorder or insomnia. Sleep disorder or insomnia is generally caused due to change in sleeping pattern, substance misuse and work issues. Most recent development in Sleep aids involves the use of specialty mattresses, high-tech pillows, drugs and at-home tests. The concept of sleep aids have outpaced the traditional methods as they are effective in reducing the time taken to fall asleep and even increase the duration of sleep thereby proving better sleep inducers than traditional aids.

The world sleep aids market is expected to register substantial growth in the near future attributed to stressful lifestyle and work schedule, rising aging population becoming susceptible to sleep disorders and increased awareness about sleep disorders. Other factors that drive the sleep aids market are increased intake of tobacco, caffeine and alcohol which causes sleep disorders. However, side effects of drugs such as head ache, vomiting and constipation are likely to restrain the growth of the market. Moreover, the patent expiration of the major sleeping drugs causes huge financial loss to the sleep aids market.

Access Full Report: http://www.intenseresearch.com/market-analysis/world-sleep-aids-market-opportunities-and-forecast-2014.html

The report segments the sleep aids market on the basis of sleep disorders, product and by medication. According to the sleep disorder, market is segmented into insomnia sleep apnea, restless legs syndrome, narcolepsy and sleep walking. On the basis of product the market is classified into the mattresses and pillows, sleep laboratories, medications and sleep apnea devices. On the basis of medication, market is segregated into prescription based drugs, OTC drugs and herbal drugs. Geographic breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific and LAMEA.

Further advancements such as increased usage of home sleep test and continuous positive airway pressure (CPAP) therapy for diagnosis of sleep apnea and growing adoption of wearable monitors and passive-off body sensors have propelled the growth of the market. In addition the growing acceptance of mattresses and pillows, sleeping aid medications (sleeping drugs), sleep laboratories, sleep apnea devices have increased the demand for sleeping aids.

Request a Brochure of This Report, here: http://bit.ly/2cMdugM

The key companies operating in the global sleeping aids market include Royal Philips, N.V Merck & Co., Sanofi, DeVilbiss Healthcare LLC , Pfizer Inc., SleepMed Inc., Cadwell Laboratories Inc., Compumedics Limited, Natus Medical Incorporated, , GlaxoSmithKline PLC., Teva Pharmaceutical Industries Ltd. Takeda Pharmaceutical Company Limited and CareFusion Corporation.

About Intense Research

Intense Research provides a range of marketing and business research solutions designed for our client’s specific needs based on our expert resources. The business scopes of Intense Research cover more than 30 industries includsing energy, new materials, transportation, daily consumer goods, chemicals, etc. We provide our clients with one-stop solution for all the research requirements.

Contact Us:

Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442,
United States
Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No. 1-855-465-4651
Email: sales@intenseresearch.com
Web: http://www.intenseresearch.com/

This release was published on openPR.